Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
JP Stock MarketDetailed Quotes
1376 Kaneko Seeds
- 1415
- +13+0.93%
20min DelayMarket Closed Dec 16 15:30 JST
16.66BMarket Cap13.70P/E (Static)
1415High1404Low4.70KVolume1414Open1402Pre Close6.65MTurnover152852wk High0.06%Turnover Ratio11.77MShares134052wk Low103.28EPS TTM10.69BFloat Cap1868Historical High13.70P/E (Static)7.56MShs Float625Historical Low103.28EPS LYR0.79%Amplitude33.00Dividend TTM0.65P/B100Lot Size2.33%Div YieldTTM
Kaneko Seeds Key Stats
Quarterly+Annual
YOY
| (FY)May 31, 2024 | (Q4)May 31, 2024 | (Q3)Feb 29, 2024 | (Q2)Nov 30, 2023 | (Q1)Aug 31, 2023 | (FY)May 31, 2023 | (Q4)May 31, 2023 | (Q3)Feb 28, 2023 | (Q2)Nov 30, 2022 | (Q1)Aug 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -0.93%61.6B | 1.95%23.22B | 6.41%11.83B | -6.47%12.81B | -5.83%13.73B | 2.45%62.18B | -2.26%22.78B | -3.11%11.12B | 19.48%13.7B | 0.96%14.58B |
| Cost of revenue | -1.01%52.14B | 2.30%19.82B | 8.17%10.03B | -7.00%10.81B | -7.42%11.48B | 2.87%52.67B | -2.09%19.38B | -3.53%9.27B | 20.78%11.62B | 1.82%12.4B |
| Gross profit | -0.53%9.46B | -0.10%3.4B | -2.40%1.81B | -3.49%2B | 3.20%2.25B | 0.21%9.51B | -3.20%3.41B | -0.96%1.85B | 12.67%2.08B | -3.68%2.18B |
| Operating expense | 3.31%7.98B | 3.07%2.25B | 2.43%1.86B | 2.29%1.87B | 5.45%1.99B | 0.91%7.72B | 6.28%2.19B | 3.57%1.82B | -3.34%1.83B | -3.01%1.88B |
| Operating profit | -17.17%1.48B | -5.77%1.15B | -289.08%-57.99M | -47.05%128.54M | -11.41%258.05M | -2.74%1.79B | -16.54%1.22B | -72.41%30.67M | 550.11%242.76M | -7.79%291.27M |
| Net non-operating interest income (expenses) | -22.96%-10.08M | 32.65%1.1M | -23.23%-3M | -28.03%-2.08M | -22.80%-6.1M | 2.18%-8.2M | 45.87%830K | 1.26%-2.44M | -1.56%-1.62M | -1.72%-4.97M |
| Non-operating interest income | -0.41%4.4M | ---- | ---- | ---- | ---- | 23.75%4.42M | ---- | ---- | ---- | ---- |
| Non-operating interest expense | 14.78%14.48M | -8.05%3.3M | 23.23%3M | 28.03%2.08M | 22.80%6.1M | 5.56%12.62M | 19.55%3.59M | -1.26%2.44M | 1.56%1.62M | 1.72%4.97M |
| Net investment income | -69.34%12.23M | -152.45%-37.35M | -65.56%9.13M | 187.04%4.09M | 10.61%36.36M | 246.41%39.87M | 71.05%-14.8M | 367.27%26.49M | -101.63%-4.7M | 60.15%32.87M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | -4.13M | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -374.84%-63.39M | -52.59%-10.13M | -1,840.74%-52.63M | -518.24%-619K | 99.86%-6K | 78.21%-13.35M | 29.81%-6.64M | 52.01%-2.71M | 100.38%148K | 40.12%-4.15M |
| Less:Other special charges | -88.07%1.59M | --0 | -64.31%968K | 518.24%619K | -99.86%6K | -76.10%13.35M | -29.81%6.64M | -52.01%2.71M | -100.38%-148K | 171.93%4.15M |
| Less:Write off | --61.79M | --10.13M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | -7.10%89.42M | -17.10%19.64M | -18.62%23.75M | 12.68%24.72M | -0.59%21.32M | -11.69%96.25M | 6.81%23.69M | 25.85%29.18M | -45.11%21.93M | -9.38%21.45M |
| Income before tax | -20.51%1.51B | -7.88%1.12B | -199.46%-80.75M | -40.18%154.65M | -7.98%309.62M | 2.60%1.9B | -14.40%1.22B | -38.43%81.19M | 552.51%258.52M | -3.38%336.48M |
| Income tax | -29.84%329.35M | -29.62%204.87M | -206.59%-26.94M | 20.09%50M | -9.00%101.42M | -13.88%469.46M | -28.93%291.1M | -38.48%25.27M | 324.68%41.64M | -1.34%111.46M |
| Net income | -17.43%1.18B | -1.06%918.7M | -196.24%-53.81M | -51.75%104.64M | -7.48%208.2M | 9.50%1.43B | -8.53%928.55M | -38.41%55.92M | 661.88%216.88M | -4.36%225.02M |
| Net income continuous operations | -17.43%1.18B | -1.06%918.7M | -196.24%-53.81M | -51.75%104.64M | -7.48%208.2M | 9.50%1.43B | -8.53%928.55M | -38.41%55.92M | 661.89%216.89M | -4.36%225.02M |
| Noncontrolling interests | -13.51%32K | -40.00%3K | -33.33%2K | 157.14%18K | -59.09%9K | -27.45%37K | -16.67%5K | -62.50%3K | -50.00%7K | -4.35%22K |
| Net income attributable to the company | -17.43%1.18B | -1.06%918.7M | -196.24%-53.81M | -51.76%104.63M | -7.47%208.19M | 9.50%1.43B | -8.53%928.55M | -38.41%55.92M | 661.65%216.88M | -4.36%225M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -17.43%1.18B | -1.06%918.7M | -196.24%-53.81M | -51.76%104.63M | -7.47%208.19M | 9.50%1.43B | -8.53%928.55M | -38.41%55.92M | 661.65%216.88M | -4.36%225M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -16.46%103.28 | 0.06%80.62 | -195.49%-4.66 | -51.23%9.14 | -6.48%18.18 | 10.55%123.63 | -7.59%80.57 | -37.36%4.88 | 664.46%18.74 | -3.62%19.44 |
| Diluted earnings per share | -16.46%103.28 | 0.06%80.62 | -197.51%-4.754 | -51.23%9.1378 | -6.48%18.18 | 10.55%123.63 | -7.59%80.57 | -37.42%4.8752 | 664.39%18.7376 | -3.62%19.44 |
| Dividend per share | 6.45%33 | 10.00%22 | 0 | 0.00%11 | 0 | 6.90%31 | 11.11%20 | 0 | 0.00%11 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |